For patients older than 65 years of age, the recommended maintenance dose is 15mg once daily.
PREGNANCY
Women with IBD should discontinue upadacitinib at least 4 weeks prior to conception unless there is no effective alternative therapy to maintain maternal health.13
BREASTFEEDING
Mothers with IBD currently on JAKi should not breastfeed.13
